Related Experiment Video
Updated: Sep 21, 2026

Optimized System for Cerebral Perfusion Monitoring in the Rat Stroke Model of Intraluminal Middle Cerebral Artery Occlusion
Published on: February 17, 2013
Update on cerebral hyperperfusion syndrome
Yen-Heng Lin1, Hon-Man Liu2,3
1Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan.
Insights
Cerebral hyperperfusion syndrome (CHS) is a post-procedure complication. This review details CHS epidemiology, diagnosis, and management, emphasizing uncertainties in neurointerventional surgery.
Area of Science:
- Neurology
- Neurosurgery
- Vascular Medicine
Background:
- Neurointerventional surgery is standard for cerebral vessel stenosis/occlusion.
- Endovascular thrombectomy is crucial for acute ischemic stroke.
- Cerebral hyperperfusion syndrome (CHS) is a clinical event post-revascularization.
Purpose of the Study:
- To review recent studies on CHS epidemiology, diagnosis, and management.
- To identify uncertainties in CHS understanding and treatment.
- To consider CHS in both acute and chronic cerebrovascular conditions.
Main Methods:
- Literature review of recent studies on CHS.
- Analysis of data predominantly from carotid angioplasty and stenting studies.
- Discussion of diagnostic criteria and hemodynamic assessment using imaging.
Main Results:
- CHS definition and diagnostic criteria are diverse.
- Impaired cerebrovascular autoregulation is key, but mechanisms are unclear.
- Clinical presentation and risk factors vary; diagnosis post-thrombectomy is complex, requiring consideration of reperfusion injury.
Conclusions:
- Further research is needed to clarify CHS pathophysiology and standardize diagnosis.
- Hemodynamic assessment aids pre-procedural patient selection.
- Management includes intensive blood pressure control and staged angioplasty.
Abstract:
Cerebral hyperperfusion syndrome (CHS) is a clinical syndrome following a revascularization procedure. In the past decade, neurointerventional surgery has become a standard procedure to treat stenotic or occluded cerebral vessels in both acute and chronic settings, as well as endovascular thrombectomy in acute ischemic stroke. This review aims to summarize relevant recent studies regarding the epidemiology, diagnosis, and management of CHS as well as to highlight areas of uncertainty. Extracranial and intracranial cerebrovascular diseases in acute and chronic conditions are considered. The definition and diagnostic criteria of CHS are diverse. Although impaired cerebrovascular autoregulation plays a major role in the pathophysiology of CHS, the underlying mechanism is still not fully understood. Its clinical characteristics vary in different patients. The current findings on clinical and radiological presentation, pathophysiology, incidence, and risk factors are based predominantly on carotid angioplasty and stenting studies. Hemodynamic assessment using imaging modalities is the main form of diagnosis although the criteria are distinct, but it is helpful for patient selection before an elective revascularization procedure is conducted. After endovascular thrombectomy, a diagnosis of CHS is even more complex, and physicians should consider concomitant reperfusion injury. Management and preventative measures, including intensive blood pressure control before, during, and after revascularization procedures and staged angioplasty, are discussed in detail.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema l: Introduction
Cerebral Edema ll: Pathophysiology

